Clove essential oil and its major component, eugenol: a comparative study of their in vitro antioxidant and anticancer properties

L. (clove) is a species native to subtropical countries. Its dried flower buds are rich in essential oils, which have shown insecticidal, anti-inflammatory and anaesthetic effects. This work was aimed to study the differences in antioxidant and anticancer activities between clove essential oil (CEO)...

Full description

Saved in:
Bibliographic Details
Published in:Natural product research 2024-09, p.1-8
Main Authors: Haro-González, José Nabor, Barbosa-Nuñez, Jorge Alejandro, Castillo-Herrera, Gustavo Adolfo, Estarrón-Espinosa, Mirna, Herrera-Rodríguez, Sara Elisa, Espinosa-Andrews, Hugo, Álvarez, Ángel H, Martínez-Velázquez, Moisés
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:L. (clove) is a species native to subtropical countries. Its dried flower buds are rich in essential oils, which have shown insecticidal, anti-inflammatory and anaesthetic effects. This work was aimed to study the differences in antioxidant and anticancer activities between clove essential oil (CEO) and its major component, eugenol. The chemical composition of the CEO was determined by GC-MS. The physicochemical properties and antioxidant activity were determined in CEO and eugenol. Finally, anticancer activities were assayed against seven cell lines. Chemical analysis revealed that 80% of the CEO was eugenol. The density and IR were similar, and the colour was ΔE*>3. CEO had a lower phenolic content, but similar antioxidant activity to eugenol. The anticancer activity of the CEO was greater than that of eugenol in all the cell lines except for HeLa cells. These results suggest that secondary compounds in CEO enhance its antioxidant and -anticancer activities.
ISSN:1478-6419
1478-6427
1478-6427
DOI:10.1080/14786419.2024.2404658